Pacer Advisors’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-308,380
| Closed | -$4.74M | – | 2320 |
|
|
2025
Q4 | $4.74M | Sell |
308,380
-13,739
| -4% | -$151K | 0.01% | 732 |
|
|
2025
Q3 | $3.2M | Buy |
322,119
+313,506
| +3,640% | +$3.26M | 0.01% | 857 |
|
|
2025
Q2 | $85.4K | Sell |
8,613
-13,925
| -62% | -$147K | ﹤0.01% | 2627 |
|
|
2025
Q1 | $292K | Buy |
+22,538
| New | +$298K | ﹤0.01% | 1654 |
|
|
2024
Q4 | – | Sell |
-7,491
| Closed | -$83.5K | – | 3704 |
|
|
2024
Q3 | $83.5K | Buy |
7,491
+1,680
| +29% | +$18.5K | ﹤0.01% | 2031 |
|
|
2024
Q2 | $65.3K | Sell |
5,811
-2,596,435
| -100% | -$30.2M | ﹤0.01% | 2881 |
|
|
2024
Q1 | $32.3M | Buy |
+2,602,246
| New | +$33.9M | 0.07% | 257 |
|
|
2023
Q1 | – | Sell |
-901,476
| Closed | -$9.59M | – | 2239 |
|
|
2022
Q4 | $9.59M | Buy |
901,476
+246,619
| +38% | +$2.87M | 0.05% | 349 |
|
|
2022
Q3 | $6.84M | Sell |
654,857
-254,162
| -28% | -$3.31M | 0.05% | 316 |
|
|
2022
Q2 | $11.4M | Buy |
+909,019
| New | +$9.66M | 0.09% | 203 |
|
|
2021
Q2 | – | Sell |
-8,133
| Closed | -$80K | – | 1449 |
|
|
2021
Q1 | $80K | Sell |
8,133
-10,642
| -57% | -$87.7K | ﹤0.01% | 1319 |
|
|
2020
Q4 | $84K | Buy |
18,775
+12,306
| +190% | +$55.7K | ﹤0.01% | 1381 |
|
|
2020
Q3 | $28K | Buy |
+6,469
| New | +$46.2K | ﹤0.01% | 1341 |
|
|
2018
Q4 | – | Sell |
-10,624
| Closed | -$132K | – | 687 |
|
|
2018
Q3 | $132K | Buy |
+10,624
| New | +$144K | 0.01% | 1063 |
|
|
2018
Q1 | – | Sell |
-2,925
| Closed | -$55K | – | 1061 |
|
|
2017
Q4 | $55K | Buy |
+2,925
| New | +$58.7K | ﹤0.01% | 1002 |
|
Other funds holding DVAX
Pacer Advisors's DVAX Position: Q1 2026 in Review
Pacer Advisors sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 308,380 shares — an estimated $4.74M sold.
Pacer Advisors first reported a position in DVAX in Q4 2017 and held it in 15 quarters. The position peaked at $32.3M in Q1 2024. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Pacer Advisors reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Pacer Advisors sold 308,380 Dynavax Technologies shares in Q1 2026, an estimated $4.74M.
- Pacer Advisors first reported a position in Dynavax Technologies in Q4 2017 and held it in 15 quarters.
- Pacer Advisors's Dynavax Technologies position peaked at $32.3M in Q1 2024.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.